Comprehensive Geriatric Assessment and Management for Canadian Elders With Cancer

Official Title

Clinical and Cost-effectiveness of a Comprehensive Geriatric Assessment and Management for Canadian Elders With Cancer: the 5C Study

Summary:

A multicentre two-group parallel single-blind (outcome assessor) randomized controlled trial (RCT). A cost effectiveness study alongside a clinical trial using a payer and societal perspective to study the cost-effectiveness of geriatric assessment and management compared to usual care will be conducted. Participants allocated to the control group will receive usual oncology care. Participants allocated to the intervention group will receive a comprehensive geriatric assessment and management in addition to their usual oncology care. The intervention will take 6 months to be completed. Total study follow-up will be 12 months for each participant.

Trial Description

Primary Outcome:

• Quality of Life questionnaire (QLQ) C30 Questionnaire Global quality of Life scale
• Quality of Life questionnaire (QLQ) C30 Questionnaire Global quality of Life scale

• Cost-effectiveness
• Functional status
• Functional status
• The number of geriatric issues successfully addressed for participants in intervention group
• Treatment toxicity
• Unplanned health care use
• Satisfaction with care provided
• Satisfaction with intervention
• Cancer treatment plan modification
• Overall survival
• Intervention fidelity by treatment centre

View this trial on ClinicalTrials.gov